Skip to main content

Advertisement

SpringerLink
Log in

Relationship between concentrations of IGF-1 and IGFBP-3 and preoperative depression risk, and effect of psychological intervention on outcomes of high-grade glioma patients with preoperative depression in a 2-year prospective study

  • Original Paper
  • Published:
Medical Oncology Aims and scope Submit manuscript

Abstract

Growth factors in the brain are important to depression. We investigated the relationship between serum insulin-like growth factor (IGF-1) and IGF-binding protein-3 (IGFBP-3) concentration and risk of depression and the effect of psychological intervention on outcomes of high-grade glioma patients with preoperative depression. A total of 249 high-grade glioma patients participated in blood sample collection for IGF-1 and IGFBP-3 detection by ELISA and the Hospital Anxiety and Depression Scale testing. The association between IGF-I or IGFBP-3 and depression risk was assessed using conditional logistic regression, and Student’s t tests were used to evaluate differences in change of the Karnofsky Performance Status Scale (KPS) in subgroups after performance of psychosocial intervention. The survivals of patients in subgroups were tested by Kaplan–Meier (log-rank test). We found the risk of depression was elevated with increased IGF-I (HR = 6.320, 95 % CI 2.456–16.265, top vs. bottom quartile) and IGFBP-3 concentrations (HR = 3.411, 95 % CI 1.345–8.648) after adjustment of confounders. KPS was increased significantly in the intervention groups, but not significantly in the usual care groups after performance of psychosocial intervention. The survival of depressed patients in the usual group was significantly worse than those of other subgroups after performance of psychosocial intervention. Depression is prevalent among patients with high-grade gliomas, and factors of the IGF axis are positively associated with risk of depression and might be involved in the etiology of depression in high-grade glioma patients. Depression correlates with quality of life and outcomes of patients. Therefore, some psychological interventions are needed and may help patients to relieve depression and improve the life quality of glioma patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Chakrabarti I, Cockburn M, Cozen W, Wang YP, Preston-Martin S. A population-based description of glioblastoma multiforme in Los Angeles County, 1974–1999. Cancer. 2005;104:2798–806.

    Article  PubMed  Google Scholar 

  2. Kaplan CP, Miner ME. Relationships: importance for patients with cerebral tumours. Brain Inj. 2000;14:251–9.

    Article  CAS  PubMed  Google Scholar 

  3. Litofsky NS, Resnick AG. The relationships between depression and brain tumors. J Neurooncol. 2009;94(2):153–61.

    Article  PubMed  Google Scholar 

  4. Schiepers OJ, Wichers MC, Maes M. Cytokines and major depression. Prog Neuro-Psychopharmacol Biol Psychiatry. 2005;29:201–17.

    Article  CAS  Google Scholar 

  5. Capuron L, Gumnick JF, Musselman DL, Lawson DH, Reemsnyder A, Nemeroff CB, Miller AH. Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions. Neuropsychopharmacology. 2002;26:643–52.

    Article  CAS  PubMed  Google Scholar 

  6. Maes M, Meltzer HY, Bosmans E, Bergmans R, Vandoolaeghe E, Ranjan R, Desnyder R. Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression. J Affect Disord. 1995;34:301–9.

    Article  CAS  PubMed  Google Scholar 

  7. Reiche EM, Nunes SO, Morimoto HK. Stress, depression, the immune system, and cancer. Lancet Oncol. 2004;5:617–25.

    Article  CAS  PubMed  Google Scholar 

  8. Sinikallio S, Aalto T, Airaksinen O, Herno A, Kröger H, Savolainen S, Turunen V, Viinamäki H. Depression is associated with poorer outcome of lumbar spinal stenosis surgery. Eur Spine J. 2007;16:905–12.

    Article  PubMed Central  PubMed  Google Scholar 

  9. Catt S, Chalmers A, Fallowfield L. Psychosocial and supportive-care needs in high-grade glioma. Lancet Oncol. 2008;9(9):884–91.

    Article  PubMed  Google Scholar 

  10. Mirimanoff RO, Gorlia T, Mason W, Van den Bent MJ, Kortmann RD, Fisher B, Reni M, Brandes AA, Curschmann J, Villa S, Cairncross G, Allgeier A, Lacombe D, Stupp R. Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial. J Clin Oncol. 2006;24:2563–9.

    Article  CAS  PubMed  Google Scholar 

  11. Weroha SJ, Haluska P. The insulin-like growth factor system in cancer. Endocrinol Metab Clin North Am. 2012;41(2):335–50.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  12. Glick RP, Unterman TG, Blaydes L, Hollis R. Insulin-like growth factors in central nervous system tumors. Ann NY Acad Sci. 1993;692:223–9.

    Article  CAS  PubMed  Google Scholar 

  13. Rajah R, Khare A, Lee PD, Cohen P. Insulin-like growth factor- binding protein -3 is partially responsible for high—serum-induced apoptosis in PC-3 prostate cancer cells[J]. J Endocrinol. 1999;163(3):487–94.

    Article  CAS  PubMed  Google Scholar 

  14. Rohrmann S, Linseisen J, Becker S, et al. Concentrations of IGF-I and IGFBP-3 and brain tumor risk in the European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiol Biomarkers Prev. 2011;20(10):2174–82.

    Article  CAS  PubMed  Google Scholar 

  15. Lönn S, Inskip PD, Pollak MN, Weinstein SJ, Virtamo J, Albanes D. Glioma risk in relation to serum levels of insulin-like growth factors. Cancer Epidemiol Biomarkers Prev. 2007;16(4):844–6.

    Article  PubMed  CAS  Google Scholar 

  16. Deuschle M, Blum WF, Strasburger CJ, et al. Insulin-like growth factor-I plasma concentrations are increased in depressed patients. Psychoneuroendocrinology. 1997;22:493–503.

    Article  CAS  PubMed  Google Scholar 

  17. Franz B, Buysse DJ, Cherry CR, et al. Insulin-like growth factor 1 and growth hormone binding protein in depression: a preliminary communication. J Psychiatric Res. 1999;33:121–7.

    Article  CAS  Google Scholar 

  18. Lesch KP, Rupprecht R, Müller U, et al. Insulin-like growth factor I in depressed patients and controls. Acta Psychiatr Scand. 1988;78:684–8.

    Article  CAS  PubMed  Google Scholar 

  19. Rupprecht R, Rupprecht C, Rupprecht M, Noder M, Lesch KP, Mössner J. Effects of glucocorticoids on the regulation of the hypothalamic-pituitary-somatotropic system in depression. J Affect Disord. 1989;17(1):9–16.

    Article  CAS  PubMed  Google Scholar 

  20. Cheng JX, Zhang X, Liu BL. Health-related quality of life in patients with high-grade glioma. Neuro Oncol. 2009;11(1):41–50.

    Article  PubMed Central  PubMed  Google Scholar 

  21. Giovagnoli A, Tamburini M, Boiardi A. Quality of life in brain tumor patients. J Neurooncol. 1996;30:71–80.

    Article  CAS  PubMed  Google Scholar 

  22. Weitzner MA, Meyers CA, Byrne K. Psychosocial functioning and quality of life in patients with primary brain tumors. J Neurosurg. 1996;84:29–34.

    Article  CAS  PubMed  Google Scholar 

  23. Stephen S, Andrew B, Marie J. The Sage hand book of health psychology. 1st ed. Thousand Oaks: Sage Publications; 2004.

    Google Scholar 

  24. van der Meulen IC, May AM, Ros WJG, Oosterom M, Hordijk G-J, Koole R, Rob J, de Leeuw J. One-year effect of a nurse-led psychosocial intervention on depressive symptoms in patients with head and neck cancer: a randomized controlled trial. Oncologist. 2013;18:336–44.

    Article  PubMed Central  PubMed  Google Scholar 

  25. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3rd ed. Washington: American Psychiatric Association; 1980.

    Google Scholar 

  26. Sellick SM, Crooks DL. Depression and cancer: an appraisal of the literature for prevalence, detection, and practice guideline development for psychological intervention. Psychooncology. 1999;8:315–33.

    Article  CAS  PubMed  Google Scholar 

  27. Spiegel D, Giese-Davis J. Depression and cancer: mechanisms and disease progression. Biol Psychiatry. 2003;54(3):269–82.

    Article  PubMed  Google Scholar 

  28. Moyad MA, Pienta KJ. Mind-body effect: insulin like growth factor-1; clinical depression; and breast, prostate, and other cancer risk-an unmeasured and masked mediator of potential significance? Urology. 2002;59:4–8.

    Article  PubMed  Google Scholar 

  29. Osoba D, Aaronson NK, Muller M, Sneeuw K, Hsu WA, Yung WK, Brada M, Newlands E. The development and psychometric validation of a brain cancer quality-of-life questionnaire for use in combination with general cancer specific questionnaires. Qual Life Res. 1996;5:139–50.

    Article  CAS  PubMed  Google Scholar 

  30. Weitzner MA, Meyers CA. Cognitive functioning and quality of life in malignant glioma patients: a review of the literature. Psychooncology. 1997;6:169–77.

    Article  CAS  PubMed  Google Scholar 

  31. Kaplan CP. Community integration questionnaire for patients with brain tumor. A comparative study. Am J Phys Med Rehabil. 2000;79:243–6.

    Article  CAS  PubMed  Google Scholar 

  32. Bailey RK, Geyen DJ, Scott-Gurnell K, Hipolito MM, Bailey TA, Beal JM. Understanding and treating depression among cancer patients. Int J Gynecol Cancer. 2005;15:203–8.

    Article  CAS  PubMed  Google Scholar 

  33. Ader R, Cohen N, Felten D. Psychoneuroimmunology: interactions between the nervous system and the immune system. Lancet. 1995;345:99–103.

    Article  CAS  PubMed  Google Scholar 

  34. Yirmiya R. Depression in medical illness: the role of the immune system. West J Med. 2000;173(5):333–6.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  35. Rinaldi S, Cleveland R, Norat T, Biessy C, Rohrmann S, Linseisen J, et al. Serum levels of IGF-I, IGFBP-3 and colorectal cancer risk: results from the EPIC cohort, plus a meta-analysis of prospective studies. Int J Cancer. 2010;126:1702–15.

    CAS  PubMed  Google Scholar 

  36. Roddam AW, Allen NE, Appleby P, Key TJ, Ferrucci L, Carter HB, et al. Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies. Ann Intern Med. 2008;149:461–71.

    Article  PubMed Central  PubMed  Google Scholar 

  37. Galan P, Key TJ, Appleby PN, Reeves GK, Roddam AW. Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies. Lancet Oncol. 2010;11:530–42.

    Article  CAS  Google Scholar 

  38. Penninx BW, Guralnik JM, Pahor M, et al. Chronically depressed mood and cancer risk in older persons. J Natl Cancer Inst. 1998;90:1888–93.

    Article  CAS  PubMed  Google Scholar 

  39. Franz B, Buysse DJ, Cherry CR, et al. Insulin-like growth factor 1 and growth hormone binding protein in depression: a preliminary communication. J Psychiatr Res. 1999;33:121–7.

    Article  CAS  PubMed  Google Scholar 

  40. Huynh HT, Tetenes E, Wallace L, et al. In vivo inhibition of insulin-like growth factor I gene expression by tamoxifen. Cancer Res. 1993;53:1727–30.

    CAS  PubMed  Google Scholar 

  41. Guvakova MA, Surmacz E. Tamoxifen interferes with the insulin-like growth factor I receptor (IGF-IR) signaling pathway in breast cancer cells. Cancer Res. 1997;57:2606–10.

    CAS  PubMed  Google Scholar 

  42. Corsello SM, Rota CA, Putignano P, et al. Effect of acute and chronic administration of tamoxifen on GH response to GHRH and on IGF-1 serum levels in women with breast cancer. Eur J Endocrinol. 1998;139:309–13.

    Article  CAS  PubMed  Google Scholar 

  43. Aberg ND, Brywe KG, Isgaard J. Aspects of growth hormone and insulin-like growth factor-I related to neuroprotection, regeneration, and functional plasticity in the adult brain. Sci World J. 2006;6:53–80.

    Article  CAS  Google Scholar 

  44. van Dam PS, Aleman A. Insulin-like growth factor-I, cognition and brain aging. Eur J Pharmacol. 2004;490:87–95.

    Article  PubMed  CAS  Google Scholar 

  45. Carro E, Torres-Aleman I. The role of insulin and insulin-like growth factor I in the molecular and cellular mechanisms underlying the pathology of Alzheimer’s disease. Eur J Pharmacol. 2004;490:127–33.

    Article  CAS  PubMed  Google Scholar 

  46. Bondy CA, Cheng CM. Signaling by insulin-like growth factor 1 in brain. Eur J Pharmacol. 2004;490:25–31.

    Article  CAS  PubMed  Google Scholar 

  47. Zumkeller W, Westphal M. The IGF/IGFBP system in CNS malignancy. Mol Pathol. 2001;54:227–9.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  48. Glick RP, Lichtor T, Unterman TG. Insulin-like growth factors in central nervous system tumors. J Neurooncol. 1997;35:315–25.

    Article  CAS  PubMed  Google Scholar 

  49. Tranque PA, Calle R, Naftolin F, Robbins R. Involvement of protein kinase-C in the mitogenic effect of insulin-like growth factor-I on rat astrocytes. Endocrinology. 1992;131:1948–54.

    CAS  PubMed  Google Scholar 

  50. Aberg ND, Blomstrand F, Aberg MA, Björklund U, Carlsson B, Carlsson-Skwirut C, Bang P, Rönnbäck L, Eriksson PS. Insulin-like growth factor-I increases astrocyte intercellular gap junctional communication and connexion 43 expression in vitro. J Neurosci Res. 2003;74:12–22.

    Article  CAS  PubMed  Google Scholar 

  51. Pan W, Kastin AJ. Interactions of IGF-1 with the blood-brain barrier in vivo and in situ. Neuroendocrinology. 2000;72:171–8.

    Article  CAS  PubMed  Google Scholar 

  52. Lönn S, Rothman N, Shapiro WR, Fine HA, Selker RG, Black PM, et al. Genetic variation in insulin-like growth factors and brain tumor risk. Neuro Oncol. 2008;10:553–9.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  53. Zumkeller W. IGFs and IGF-binding proteins as diagnostic markers and biological modulators in brain tumors. Expert Rev Mol Diagn. 2002;2:473–7.

    Article  CAS  PubMed  Google Scholar 

  54. Mainio A, Hakko H, Niemela A, Koivukangas J, Rasanen P. Depression and functional outcome in patients with brain tumors: a population-based 1-year follow-up study. J Neurosurg. 2005;103:841–7.

    Article  PubMed  Google Scholar 

  55. Gathinji M, McGirt MJ, Attenello FJ, Chaichana KL, Than K, Olivi A, Weingart JD, Brem H, Quinones-Hinojosa A. Association of preoperative depression and survival after resection of malignant brain astrocytoma. Surg Neurol. 2009;71(3):299–303.

    Article  PubMed  Google Scholar 

  56. Brown PD, Maurer MJ, Rummans TA, Pollock BE, Ballman KV, Sloan JA, Boeve BF, Arusell RM, Clark MM, Buckner JC. A prospective study of quality of life in adults with newly diagnosed high-grade gliomas: the impact of the extent of resection on quality of life and survival. Neurosurgery. 2005;57:495–504.

    Google Scholar 

  57. Litofsky NS, Farace E, Anderson F, Meyers CA, Huang W, Laws ER, Glioma Outcomes Project Investigators. Depression in patients with high-grade glioma: results of the Glioma Outcomes Project. Neurosurgery. 2004;54(2):358–66.

    Article  PubMed  Google Scholar 

  58. Mackworth N, Fobair P, Prados MD. Quality of life self reports from 200 brain tumor patients: comparisons with Karnofsky performance scores. J Neurooncol. 1992;14:243–53.

    Article  CAS  PubMed  Google Scholar 

  59. Williams S, Dale J. The effectiveness of treatment for depression/depressive symptoms in adults with cancer: a systematic review. Br J Cancer. 2006;94:372–90.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  60. Jacobsen PB, Jim HS. Psychosocial Interventions for anxiety and depression in adult cancer patients: achievements and challenges. CA Cancer J Clin. 2008;58:214–30.

    Article  PubMed  Google Scholar 

  61. Osborn RL, Demoncada AC, Feuerstein M. Psychosocial interventions for depression, anxiety, and quality of life in cancer survivors: meta-analyses. Int J Psychiatry Med. 2006;36:13–34.

    Article  PubMed  Google Scholar 

  62. Rodin G, Lloyd N, Katz M, et al. The treatment of depression in cancer patients: a systematic review. Support Care Cancer. 2007;15:123–36.

    Article  PubMed  Google Scholar 

  63. Lurati C, Riva M, Resega R, et al. A mono-institutional prospective study on the effectiveness of a specialist psychotherapeutic intervention (POI) started at the diagnosis of cancer. Support Care Cancer. 2012;20:475–81.

    Article  PubMed  Google Scholar 

  64. Petersen RW, Quinlivan JA. Preventing anxiety and depression in gynaecological cancer: a randomized controlled trial. BJOG. 2002;109:386–94.

    Article  PubMed  Google Scholar 

  65. Rawl SM, Given BA, Given CW, et al. Intervention to improve psychological functioning for newly diagnosed patients with cancer. Oncol Nurs Forum. 2002;29:967–75.

    Article  PubMed  Google Scholar 

  66. McLachlan SA, Allenby A, Matthews J, Wirth A, Kissane D, Bishop M, Beresford J, Zalcberg J. Randomized trial of coordinated psychosocial interventions based on patient self-assessments versus standard care to improve the psychosocial functioning of patients with cancer. J Clin Oncol. 2001;19(21):4117–25.

    CAS  PubMed  Google Scholar 

  67. Winzelberg AJ, Classen C, Alpers GW, et al. Evaluation of an internet support group for women with primary breast cancer. Cancer. 2003;97:1164–73.

    Article  PubMed  Google Scholar 

  68. Weber BA, Roberts BL, Resnick M, et al. The effect of dyadic intervention on self-efficacy, social support, and depression for men with prostate cancer. Psycho-oncology. 2004;13:47–60.

    Article  PubMed  Google Scholar 

  69. Porter LS, Keefe FJ, Garst J, et al. Caregiver-assisted coping skills training for lung cancer: results of a randomized clinical trial. J Pain Symptom Manage. 2011;41:1–13.

    Article  Google Scholar 

  70. Sharpe M, Strong V, Allen K, et al. Management of major depression in outpatients attending a cancer centre: a preliminary evaluation of a multicomponent cancer nurse-delivered intervention. Br J Cancer. 2004;90:310–3.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  71. Strong V, Waters R, Hibberd C, et al. Management of depression for people with cancer (SMaRT oncology 1): a randomised trial. Lancet. 2008;372:40–8.

    Article  PubMed  Google Scholar 

  72. de Leeuw JR, de Graeff A, Ros WJ, Blijham GH, Hordijk GJ, Winnubst JA. Prediction of depression 6 months to 3 years after treatment of head and neck cancer. Head Neck. 2001;23:892–8.

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

No conflict of interest exits in the submission of this manuscript, and manuscript is approved by all authors for publication. I would like to declare on behalf of my co-authors that the work described was original research that has not been published previously, and not under consideration for publication elsewhere, in whole or in part.

Author information

Authors and Affiliations

  1. Department of Neurosurgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China

    Yan Wang, Jian-tong Jiao, Tao-hui Ouyang, Ju Huang, Sha-sha Liu & Chun-lin Li

  2. Department of Blood Screening Test, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China

    Ming Huang

  3. Department of Emergency, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China

    Yan-li Wu

Authors
  1. Yan Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ming Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jian-tong Jiao
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yan-li Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Tao-hui Ouyang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ju Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Sha-sha Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Chun-lin Li
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Chun-lin Li.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wang, Y., Huang, M., Jiao, Jt. et al. Relationship between concentrations of IGF-1 and IGFBP-3 and preoperative depression risk, and effect of psychological intervention on outcomes of high-grade glioma patients with preoperative depression in a 2-year prospective study. Med Oncol 31, 921 (2014). https://doi.org/10.1007/s12032-014-0921-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s12032-014-0921-8

Keywords

Search

Navigation